Clinical Trial

DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage

Study acronym: GLAMOR
Recruiting
View on ClinicalTrials.gov →
Summary
Intracerebral hemorrhage (ICH) is a devastating disease with high early mortality, unfavorable neurological outcomes, and high cost of care. To date, the role of DTI-guided minimally invasive hematoma evacuation in ICH is still uncertain. The investigators will conduct a multicenter randomized controlled trial, as well as a concurrent prospective observational study including all ICH patients who decline participation in the trial and will therefore receive minimally invasive hematoma evacuation or best medical therapy and consent to be followed up. All participants will be followed up at the same time using the same outcomes measures. The primary outcome will be collected by a blinded assessor.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-05; most recent amendment 2023-09-08.
Status change: Not Yet Recruiting → Recruiting 2023-09-07
Trial Details
NCT Number NCT05891509
Lead Sponsor Zhongming Qiu
Collaborators: Xingguo County People's Hospital
Conditions Stroke Hemorrhagic
Enrollment 100 participants
Start Date 2023-08-03
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2023-09-13